Steven Cohen’s Purple Biotech PPBT Stock Holding History

Steven Cohen’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,357	Closed	-$1.07M	–	1588
2022 Q1	$1.07M	Sell	1,357 -39	-3%	-$25.2K	﹤0.01%	948
2021 Q4	$1.09M	Hold	1,396	–	–	﹤0.01%	900
2021 Q3	$1.28M	Sell	1,396 -1,229	-47%	-$1.19M	0.01%	833
2021 Q2	$2.56M	Buy	+2,625	New	+$2.41M	0.01%	704

Other funds holding PPBT

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WTB

Washington Trust Bank Spokane, Washington $1.43B AUM 25.27% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Steven Cohen's PPBT Position: Q2 2022 in Review

Steven Cohen sold out of Purple Biotech (PPBT) in Q2 2022, closing a stake of 1,357 shares — an estimated $1.07M sold.

Steven Cohen first reported a position in PPBT in Q2 2021 and held it in 4 quarters. The position peaked at $2.56M in Q2 2021. 12 funds tracked by Wall St. Rank hold PPBT as of Q2 2022.

Steven Cohen reported no remaining Purple Biotech position as of Q2 2022 after selling out during the quarter.
Steven Cohen sold 1,357 Purple Biotech shares in Q2 2022, an estimated $1.07M.
Steven Cohen first reported a position in Purple Biotech in Q2 2021 and held it in 4 quarters.
Steven Cohen's Purple Biotech position peaked at $2.56M in Q2 2021.
12 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2022.

Based on Point72 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.